Alkahest Company
Alkahest develops therapies derived from blood to treat neurological diseases, with an emphasis on age-related cognitive decline.
Founded Date:
2014-01-01
Total Funding:
41
Investor Type:
Company
Employee Number:
11-50
Funding Status:
M&A
Number Of Exists:
Grant
Technology:
Biotechnology, Health Care, Medical
Last Funding Type:
Venture - Series Unknown
Investors Number:
2
Industry:
End-to-end Drug Development
Headquarters:
San Carlos, California, United States
Estimated Revenue:
Less than $1M